
Antiparasitics
Antiparasitics are compounds designed to treat and prevent parasitic infections by inhibiting the growth and survival of parasites. This category includes a range of antiparasitic agents intended exclusively for laboratory use and not for human consumption. These products are essential for research purposes, allowing scientists to study parasitic life cycles, mechanisms of action, and the development of resistance. The use of antiparasitics in laboratory settings aids in the discovery and optimization of new treatments for parasitic diseases, contributing to advancements in medical and veterinary parasitology. Researchers rely on these products to enhance their understanding of parasitic infections and to develop more effective therapies.
Products of "Antiparasitics"
Sort by
PF 1022A
CAS:PF 1022A is a cyclooctadepsipeptide, which is a type of cyclic peptide composed of amino acids and hydroxy acids. It is derived from the fermentation products of the fungus *Mycelia sterilia*, a member of the *Rosellinia* genus. Its mode of action involves disrupting glutamate-gated chloride channels in parasitic nematodes, which leads to paralysis and eventual death of the parasite. PF 1022A is primarily used for its anthelmintic properties, making it useful for controlling parasitic worm infections in animals. The compound's ability to selectively target nematodes without significant harm to the host organism makes it a valuable tool in veterinary medicine. It serves as a key component in formulations designed to combat gastrointestinal nematodes in livestock and pets, contributing to enhanced health and productivity in affected animals. Research into PF 1022A continues to explore its full potential and further applications in parasitology.Formula:C52H76N4O12Purity:Min. 95%Molecular weight:949.18 g/molCipargamin
CAS:Cipargamin (NITD609) is an effective antimalarial compound. It has an IC50 of appr 1 nM against P. falciparum.Formula:C19H14Cl2FN3OPurity:98.58%Color and Shape:SolidMolecular weight:390.24Ref: TM-T16326
1mg38.00€5mg93.00€10mg135.00€25mg250.00€50mg424.00€100mg677.00€200mg900.00€1mL*10mM (DMSO)93.00€Benznidazole
CAS:Benznidazole is an antiprotozoal agent and is used for the treatment of Chagas disease. It generates free radicals that damage the DNA and other cellular components of the parasite.Formula:C12H12N4O3Purity:Min. 97 Area-%Color and Shape:White PowderMolecular weight:260.25 g/molRef: TM-T5S2358
1mg57.00€2mg81.00€5mg111.00€10mg160.00€25mg263.00€50mg378.00€100mg558.00€200mg797.00€1mL*10mM (DMSO)123.00€Nanaomycin A
CAS:Nanaomycin A, a quinone antibiotic, reactivates cancer suppressor genes and inhibits DNMT3B (IC50=500nM).Formula:C16H14O6Purity:98%Color and Shape:SolidMolecular weight:302.28Antimalarial agent 45
Antimalarial agent 45 (compound 8I) is an antimalarial with activity against Plasmodium parasites, exhibiting an IC50 of 0.21 μM. It is used in the study of malaria.Formula:C33H34N4O3Color and Shape:SolidMolecular weight:534.65Ornidazole (Levo-)
CAS:Ornidazole (Levo-) (Levornidazole) is the levo-isomer of Ornidazole.Formula:C7H10ClN3O3Purity:99.60%Color and Shape:SolidMolecular weight:219.63Doramectin
CAS:Doramectin is a macrocyclic lactone antiparasitic agent with action on glutamate-gated chloride channels in parasites and is used for treating internal and external parasitic infections in livestock.Formula:C50H74O14Purity:Min. 95%Color and Shape:White PowderMolecular weight:899.11 g/mol2,4-Pteridinediamine-6-methanol
CAS:Controlled ProductFormula:C7H8N6OColor and Shape:NeatMolecular weight:192.18TSO-13
TSO-13 is an inhibitor of the major cysteine protease Cruzipain found in Trypanosoma cruzi, with an IC50 of 2.2 μM. In Vero cells, TSO-13 also suppresses T. cruzi, exhibiting an IC50 of 1.9 μM.Formula:C32H36N4O4S2Color and Shape:SolidMolecular weight:604.78Fenbendazole
CAS:Fenbendazole (Fenbendazol) is an antinematodal benzimidazole used in veterinary medicine.Formula:C15H13N3O2SPurity:99.74%Color and Shape:White To Yellowish PowderMolecular weight:299.35Antileishmanial agent-14
CAS:Antileishmanial agent-14, a sulfuretin analog, exhibits potential activity against Leishmania donovani promastigotes (IC 50 = 4.1 μM) and inhibits infection byFormula:C23H26ClNO5Purity:98%Color and Shape:SolidMolecular weight:431.91Niclosamide Piperazinesalt
CAS:Controlled ProductFormula:C13H8Cl2N2O4·C4H10N2Color and Shape:NeatMolecular weight:413.26Fenbendazole
CAS:Fenbendazole is a benzimidazole anthelmintic with action on microtubule formation in parasites and is used for treating gastrointestinal parasites in animals.Formula:C15H13N3O2SPurity:Min. 97.5 Area-%Color and Shape:PowderMolecular weight:299.35 g/molAlbendazole
CAS:Formula:C12H15N3O2SPurity:>98.0%(N)Color and Shape:White to Almost white powder to crystalMolecular weight:265.33Temephos
CAS:Temephos is an organothiophosphate insecticide and cholinesterase inhibitor for treating water with disease-carrying insects.Formula:C16H20O6P2S3Purity:≥95%Color and Shape:White Crystalline Solid Or LiquidMolecular weight:466.47Antileishmanial agent-23
CAS:Antileishmanial agent-23 (compound G1/9), a potent and selective trypanothione reductase (TR) inhibitor, exhibits an IC50 of 2.24 ± 0.52 μM.Formula:C20H17N3O4S2Purity:98%Color and Shape:SolidMolecular weight:427.5D-Phenothrin
CAS:D-Phenothrin is a synthetic pyrethroid used in vet medicine for pest control and to kill insects, mosquitoes, and lice.Formula:C23H26O3Purity:99.26%Color and Shape:Colorless Liquid Pale Yellow-To-Yellow-Brown LiquidMolecular weight:350.45Amoscanate
CAS:Amoscanate is an antischistosomal agent, which is a synthetic compound with a broad spectrum of activity against parasitic infections. Its mode of action involves the disruption of parasite metabolism and structure, ultimately leading to the elimination of schistosomes. Schistosomes are trematode worms responsible for schistosomiasis, a significant parasitic disease affecting millions of people worldwide. In terms of its applications, Amoscanate is primarily used in the treatment and management of schistosomiasis, where it targets both the adult and larval stages of the parasite. The synthetic origin of Amoscanate allows for precise adjustments in its chemical structure, optimizing efficacy and minimizing adverse effects. Research on its mechanism indicates that Amoscanate interferes with key biological pathways within the parasite, thereby eradicating the infection. While its current use might be focused on helminthic diseases, ongoing studies aim to elucidate additional therapeutic potential. The growing interest in this compound underscores the need for novel therapies in the treatment of neglected tropical diseases.Formula:C13H9N3O2SPurity:Min. 95%Molecular weight:271.3 g/mol